Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Revenue

In the year 2024, Tonix Pharmaceuticals Holding had annual revenue of $10.09M with 29.94% growth. Tonix Pharmaceuticals Holding had revenue of $2.58M in the quarter ending December 31, 2024, a decrease of -31.68%.

• Revenue (ttm): $10.09M
• Revenue Growth: +29.94%
• P/S Ratio: 1.15
• Revenue / Employee: $124,617
• Employees: 81
• Market Cap: 101.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.09M	2.33M	29.94%
Dec 31, 2023	7.77M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.